Cargando…

Rebound of platelet count in a patient with type 2 calreticulin-mutant essential thrombocythemia in the postpartum period: A case report

INTRODUCTION: Essential thrombocythemia (ET) is an uncommon myeloproliferative neoplasm. It is more common in females; 20% of them are below 40 years old. The optimal management of ET during pregnancy and postpartum periods is still not well established. PATIENT CONCERN: We report a case of a young...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-Mashdali, Abdulrahman F., Yassin, Mohamed A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568366/ https://www.ncbi.nlm.nih.gov/pubmed/34871269 http://dx.doi.org/10.1097/MD.0000000000027725

Ejemplares similares

Marked Rebound of Platelet Count in the Early Postpartum Period in a Patient with Essential Thrombocythemia
por: Hashimoto, Yoshinori, et al.
Publicado: (2021)

Mutant calreticulin causes essential thrombocythemia
por: Shimoda, Kazuya, et al.
Publicado: (2017)

Ruxolitinib (a JAK2 inhibitor) as an emerging therapy for refractory pruritis in a patient with low-risk polycythemia vera: A case report
por: Al-Mashdali, Abdulrahman F., et al.
Publicado: (2021)

Recurrent spinal cord compression due to extramedullary hematopoiesis in thalassemia patient: Case report
por: Abbarh, Shahem, et al.
Publicado: (2022)

A study of (18)F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia
por: Yassin, Mohamed A., et al.
Publicado: (2020)

Use of rivaroxaban in sickle cell disease and venous thromboembolism: A case report
por: Rozi, Waail, et al.
Publicado: (2021)

Acute hemolysis and methemoglobinemia secondary to fava beans ingestion in a patient with G6PD deficiency: A case report of a rare co-occurrence
por: Al-Dubai, Husam, et al.
Publicado: (2021)

JAK2 V617F-positive essential thrombocythemia with subsequent development of immune thrombocytopenia: A case report
por: Oda, Yasuhiro, et al.
Publicado: (2019)

Structural and Dynamic Differences between Calreticulin Mutants Associated with Essential Thrombocythemia
por: Radjasandirane, Ragousandirane, et al.
Publicado: (2023)

Essential thrombocythemia with (type2) calreticulin presented as stuttering priapism case report and review of literature
por: Ali, Elrazi Awadelkarim, et al.
Publicado: (2020)

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
por: Shide, K, et al.
Publicado: (2017)

Extreme Levels of Platelet Count in Essential Thrombocythemia: Management and Outcome, Report of Two Cases
por: Abu-Tineh, Mohammad, et al.
Publicado: (2020)

Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia
por: Dai, Qingkai, et al.
Publicado: (2021)

Alterations of Signaling Pathways in Essential Thrombocythemia with Calreticulin Mutation
por: Hui, Wuhan, et al.
Publicado: (2021)

Association of interleukin-28B polymorphisms with platelet count and liver function recovery after liver transplant
por: Li, Yi, et al.
Publicado: (2017)

Comparison of Clinical and Hematological Parameters of Janus Kinase 2, Calreticulin or Myeloproliferative Leukemia Virus Oncogene Mutant Essential Thrombocythemia and Triple-Negative Essential Thrombocythemia
por: Yıldız, Jale, et al.
Publicado: (2022)

Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
por: Nazha, Bassel, et al.
Publicado: (2015)

Calreticulin in Essential Thrombocythemia: StressINg OUT the Megakaryocyte Nucleus
por: Iborra, Francisco Jose, et al.
Publicado: (2017)

Myocardial Infarction as an Initial Presentation of Essential Thrombocythemia With Calreticulin (CALR) Mutation (None Type 1, None Type 2)
por: Afana, Mohammad, et al.
Publicado: (2023)

Two Novel Monoallelic Calreticulin Mutations in a Patient With Essential Thrombocythemia
por: Kamory, Eniko, et al.
Publicado: (2017)

Immature platelet fraction: A useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery
por: Jeon, Kibum, et al.
Publicado: (2020)

Neutrophil/Lymphocyte Ratio, Lymphocyte/Monocyte Ratio, and Absolute Lymphocyte Count/Absolute Monocyte Count Prognostic Score in Diffuse Large B-Cell Lymphoma: Useful Prognostic Tools in the Rituximab Era
por: Ho, Ching-Liang, et al.
Publicado: (2015)

Unexpected high platelet counts in a potential platelet donor: A clue to essential thrombocythemia
por: Navkudkar, Anisha, et al.
Publicado: (2020)

Hematological indices reference intervals for a healthy Arab population in Qatar: Effect of age, gender, and geographic location
por: Yassin, Mohamed A., et al.
Publicado: (2022)

The associations between leukocyte, erythrocyte or platelet, and metabolic syndrome in different genders of Chinese
por: Zhou, Pingping, et al.
Publicado: (2016)

Successful management of severe allergic reactions to platelet transfusion with omalizumab: A case report
por: Choi, Yeonjoo, et al.
Publicado: (2021)

The prognostic value of the peripheral blood cell counts changes during induction chemotherapy in Chinese patients with adult acute myeloid leukemia
por: Huang, Yuan-Mao, et al.
Publicado: (2021)

Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia
por: Tosetto, Alberto, et al.
Publicado: (2021)

Biomarkers involved in evaluation of platelets function in South-Eastern Romanian patients with hematological malignancies subtypes
por: Matei, Elena, et al.
Publicado: (2021)

Denosumab versus zoledronic acid for patients with beta-thalassemia major-induced osteoporosis
por: Yassin, Mohamed A., et al.
Publicado: (2020)

Tumor lysis syndrome in chronic lymphocytic leukemia: conventional treatment versus novel agents: A protocol for systematic review and meta-analysis
por: Kassem, Nancy, et al.
Publicado: (2020)

Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML
por: Chen, Xiangli, et al.
Publicado: (2023)

The prevalence of factor VIII and IX inhibitors among Saudi patients with hemophilia: Results from the Saudi national hemophilia screening program
por: Owaidah, Tarek, et al.
Publicado: (2017)

Myeloid tumors accompanying systemic mastocytosis, basophilia, and abnormal platelet-derived growth factor receptor β: A case report
por: Li, Yanfen, et al.
Publicado: (2021)

Hematological relevance of JAK2 V617F and calreticulin mutations in Tunisian patients with essential thrombocythemia
por: Abdelghani, Maroua, et al.
Publicado: (2022)

Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients
por: Qin, Ya-Zhen, et al.
Publicado: (2016)

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia
por: Buxhofer‐Ausch, Veronika, et al.
Publicado: (2020)

1.5 million platelet count limit at essential thrombocythemia diagnosis: correlations and relevance to vascular events
por: Gangat, Naseema, et al.
Publicado: (2022)

Thrombophilic Risk of Factor V Leiden, Prothrombin G20210A, MTHFR, and Calreticulin Mutations in Essential Thrombocythemia Egyptian Patients
por: El-Ghonemy, Mohamed S., et al.
Publicado: (2020)

Comparative effectiveness and safety of direct-acting oral anticoagulants (DOACS) for the reduction of recurrent venous thromboembolism in cancer patients: A protocol for systematic review and network meta-analysis using a generalized pairwise modeling methodology
por: Danjuma, Mohammed ibn-Mas’ud, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8lriqfe53fi2os8co93h8dqor7